Literature DB >> 29107642

Linking EPCR-Binding PfEMP1 to Brain Swelling in Pediatric Cerebral Malaria.

Anne Kessler1, Selasi Dankwa2, Maria Bernabeu2, Visopo Harawa3, Samuel A Danziger2, Fergal Duffy2, Sam D Kampondeni4, Michael J Potchen5, Nicholas Dambrauskas2, Vladimir Vigdorovich2, Brian G Oliver2, Sarah E Hochman6, Wenzhu B Mowrey1, Ian J C MacCormick7, Wilson L Mandala8, Stephen J Rogerson9, D Noah Sather2, John D Aitchison2, Terrie E Taylor10, Karl B Seydel11, Joseph D Smith12, Kami Kim13.   

Abstract

Brain swelling is a major predictor of mortality in pediatric cerebral malaria (CM). However, the mechanisms leading to swelling remain poorly defined. Here, we combined neuroimaging, parasite transcript profiling, and laboratory blood profiles to develop machine-learning models of malarial retinopathy and brain swelling. We found that parasite var transcripts encoding endothelial protein C receptor (EPCR)-binding domains, in combination with high parasite biomass and low platelet levels, are strong indicators of CM cases with malarial retinopathy. Swelling cases presented low platelet levels and increased transcript abundance of parasite PfEMP1 DC8 and group A EPCR-binding domains. Remarkably, the dominant transcript in 50% of swelling cases encoded PfEMP1 group A CIDRα1.7 domains. Furthermore, a recombinant CIDRα1.7 domain from a pediatric CM brain autopsy inhibited the barrier-protective properties of EPCR in human brain endothelial cells in vitro. Together, these findings suggest a detrimental role for EPCR-binding CIDRα1 domains in brain swelling.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EPCR; PfEMP1; Plasmodium falciparum; brain swelling; cerebral malaria; var

Mesh:

Substances:

Year:  2017        PMID: 29107642      PMCID: PMC5783720          DOI: 10.1016/j.chom.2017.09.009

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  62 in total

1.  Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles.

Authors:  George M Warimwe; Gregory Fegan; Jennifer N Musyoki; Charles R J C Newton; Michael Opiyo; George Githinji; Cheryl Andisi; Francis Menza; Barnes Kitsao; Kevin Marsh; Peter C Bull
Journal:  Sci Transl Med       Date:  2012-04-11       Impact factor: 17.956

2.  Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant.

Authors:  Jens E V Petersen; Eveline A M Bouwens; Ibai Tamayo; Louise Turner; Christian W Wang; Monique Stins; Thor G Theander; José Hermida; Laurent O Mosnier; Thomas Lavstsen
Journal:  Thromb Haemost       Date:  2015-07-09       Impact factor: 5.249

3.  Plasma concentrations of parasite histidine-rich protein 2 distinguish between retinopathy-positive and retinopathy-negative cerebral malaria in Malawian children.

Authors:  Karl B Seydel; Lindsay L Fox; Simon J Glover; Mathew J Reeves; Paul Pensulo; Alice Muiruri; Ashley Mpakiza; Malcolm E Molyneux; Terrie E Taylor
Journal:  J Infect Dis       Date:  2012-05-25       Impact factor: 7.759

4.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

5.  Differential PfEMP1 expression is associated with cerebral malaria pathology.

Authors:  Dumizulu L Tembo; Benjamin Nyoni; Rekah V Murikoli; Mavuto Mukaka; Danny A Milner; Matthew Berriman; Stephen J Rogerson; Terrie E Taylor; Malcolm E Molyneux; Wilson L Mandala; Alister G Craig; Jacqui Montgomery
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

6.  Laboratory evidence of disseminated intravascular coagulation is associated with a fatal outcome in children with cerebral malaria despite an absence of clinically evident thrombosis or bleeding.

Authors:  C A Moxon; N V Chisala; R Mzikamanda; I MacCormick; S Harding; C Downey; M Molyneux; K B Seydel; T E Taylor; R S Heyderman; C-H Toh
Journal:  J Thromb Haemost       Date:  2015-08-27       Impact factor: 5.824

7.  Structure-Guided Identification of a Family of Dual Receptor-Binding PfEMP1 that Is Associated with Cerebral Malaria.

Authors:  Frank Lennartz; Yvonne Adams; Anja Bengtsson; Rebecca W Olsen; Louise Turner; Nicaise T Ndam; Gertrude Ecklu-Mensah; Azizath Moussiliou; Michael F Ofori; Benoit Gamain; John P Lusingu; Jens E V Petersen; Christian W Wang; Sofia Nunes-Silva; Jakob S Jespersen; Clinton K Y Lau; Thor G Theander; Thomas Lavstsen; Lars Hviid; Matthew K Higgins; Anja T R Jensen
Journal:  Cell Host Microbe       Date:  2017-03-08       Impact factor: 21.023

8.  Severe malaria is associated with parasite binding to endothelial protein C receptor.

Authors:  Louise Turner; Thomas Lavstsen; Sanne S Berger; Christian W Wang; Jens E V Petersen; Marion Avril; Andrew J Brazier; Jim Freeth; Jakob S Jespersen; Morten A Nielsen; Pamela Magistrado; John Lusingu; Joseph D Smith; Matthew K Higgins; Thor G Theander
Journal:  Nature       Date:  2013-06-05       Impact factor: 49.962

9.  Serological Conservation of Parasite-Infected Erythrocytes Predicts Plasmodium falciparum Erythrocyte Membrane Protein 1 Gene Expression but Not Severity of Childhood Malaria.

Authors:  George M Warimwe; Abdirahman I Abdi; Michelle Muthui; Gregory Fegan; Jennifer N Musyoki; Kevin Marsh; Peter C Bull
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

10.  The structural basis for CD36 binding by the malaria parasite.

Authors:  Fu-Lien Hsieh; Louise Turner; Jani Reddy Bolla; Carol V Robinson; Thomas Lavstsen; Matthew K Higgins
Journal:  Nat Commun       Date:  2016-09-26       Impact factor: 14.919

View more
  50 in total

1.  Plasma cell-free DNA predicts pediatric cerebral malaria severity.

Authors:  Iset Medina Vera; Anne Kessler; Li-Min Ting; Visopo Harawa; Thomas Keller; Dylan Allen; Madi Njie; McKenze Moss; Monica Soko; Ajisa Ahmadu; Innocent Kadwala; Stephen Ray; Tonney S Nyirenda; Wilson L Mandala; Terrie E Taylor; Stephen J Rogerson; Karl B Seydel; Kami Kim
Journal:  JCI Insight       Date:  2020-06-18

Review 2.  Activated protein C in neuroprotection and malaria.

Authors:  Laurent O Mosnier
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

3.  Longitudinal analysis of naturally acquired PfEMP1 CIDR domain variant antibodies identifies associations with malaria protection.

Authors:  Nyamekye Obeng-Adjei; Daniel B Larremore; Louise Turner; Aissata Ongoiba; Shanping Li; Safiatou Doumbo; Takele B Yazew; Kassoum Kayentao; Louis H Miller; Boubacar Traore; Susan K Pierce; Caroline O Buckee; Thomas Lavstsen; Peter D Crompton; Tuan M Tran
Journal:  JCI Insight       Date:  2020-06-18

4.  Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria.

Authors:  Adriana A Marin; Oscar Murillo; Rodrigo A Sussmann; Luana S Ortolan; Daniella S Battagello; Thatyane de Castro Quirino; Jackson C Bittencourt; Sabrina Epiphanio; Alejandro M Katzin; Leonardo J M Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

5.  Getting Your Head around Cerebral Malaria.

Authors:  Jeffrey D Dvorin
Journal:  Cell Host Microbe       Date:  2017-11-08       Impact factor: 21.023

6.  Testing the effect of PAR1 inhibitors on Plasmodium falciparum-induced loss of endothelial cell barrier function.

Authors:  Janet Storm; Yang Wu; Christopher A Moxon; Alister G Craig; Jill Davies
Journal:  Wellcome Open Res       Date:  2020-07-07

7.  Immunization with Recombinant Plasmodium falciparum Erythrocyte Membrane Protein 1 CIDRα1 Domains Induces Domain Subtype Inhibitory Antibodies.

Authors:  Louise Turner; Thor G Theander; Thomas Lavstsen
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

8.  Parasite histones are toxic to brain endothelium and link blood barrier breakdown and thrombosis in cerebral malaria.

Authors:  Christopher A Moxon; Yasir Alhamdi; Janet Storm; Julien M H Toh; Dagmara McGuinness; Joo Yeon Ko; George Murphy; Steven Lane; Terrie E Taylor; Karl B Seydel; Sam Kampondeni; Michael Potchen; James S O'Donnell; Niamh O'Regan; Guozheng Wang; Guillermo García-Cardeña; Malcolm Molyneux; Alister G Craig; Simon T Abrams; Cheng-Hock Toh
Journal:  Blood Adv       Date:  2020-07-14

Review 9.  Opportunities for Host-targeted Therapies for Malaria.

Authors:  Elizabeth K K Glennon; Selasi Dankwa; Joseph D Smith; Alexis Kaushansky
Journal:  Trends Parasitol       Date:  2018-08-16

10.  Complement C1s cleaves PfEMP1 at interdomain conserved sites inhibiting Plasmodium falciparum cytoadherence.

Authors:  Yvonne Azasi; Leanne M Low; Ashley N Just; Sai S R Raghavan; Christian W Wang; Paola Valenzuela-Leon; J Alexandra Rowe; Joseph D Smith; Thomas Lavstsen; Louise Turner; Eric Calvo; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.